Prescribing low-dose aspirin for preventing secondary cardiovascular disease is well established, but its safety and efficacy in primary prevention remains open to debate.
These severe epileptic encephalopathies manifest during early childhood, often causing severe neurologic, intellectual, and behavioral disorders that progressively worsen.